Labviva, a leading SaaS application for healthcare procurement today announced an $8M Series Seed capital raise to support further development of the platform with new product lines, including investment in operations and customer success platforms. The funding closed on June 2, 2021. Led by Senator Investment Group, with other new investment from B Capital Group | Ascent and continued participation from Glasswing Ventures which led previous rounds to date.

Labviva connects researchers with suppliers of reagents, chemicals, and instrumentation in an intuitive user-friendly platform that supports the priorities of scientists while staying compliant with purchasing rules. Suppliers can easily manage their content of their products, and products are mapped into scientific applications, techniques and protocols. Learn more about how Labviva accelerates the science of life at Labviva.com

Labviva Announces $8M Series Seed Capital Raise

Description

Company Information

Labviva Announces $8M Series Seed Capital Raise

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Company Information